{
    "nct_id": "NCT06428409",
    "official_title": "A Phase 1/2 Study to Evaluate the Safety and Efficacy of MK-2870 Monotherapy or in Combination With Other Anticancer Agents in Gastrointestinal Cancers",
    "inclusion_criteria": "The main inclusion criteria include but are not limited to the following:\n\n* Has one of the following cancers:\n\n  * Unresectable or metastatic colorectal cancer\n  * Advanced or metastatic pancreatic ductal adenocarcinoma (PDAC)\n  * Advanced and/or unresectable biliary tract cancer (BTC)\n* Has received prior therapy for the cancer\n* Has recovered from any side effects due to previous cancer treatment\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "The main exclusion criteria include but are not limited to the following:\n\n* History of severe eye disease\n* Received prior systemic anticancer therapy including investigational agents within 4 weeks before starting study intervention\n* History of (noninfectious) pneumonitis/interstitial lung disease that required steroids or has current pneumonitis/interstitial lung disease",
    "miscellaneous_criteria": ""
}